Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
181.24
+1.09 (0.61%)
Oct 30, 2025, 1:01 PM EDT - Market open
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$200,429
Profits / Employee
-$3,444
Market Cap
8.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
| Dec 31, 2023 | 21,800 | 400 | 1.87% |
| Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
| Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
| Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
| Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
| Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
| Dec 30, 2017 | 11,800 | 800 | 7.27% |
| Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
| Dec 26, 2015 | 8,600 | 700 | 8.86% |
| Dec 27, 2014 | 7,900 | 200 | 2.60% |
| Dec 28, 2013 | 7,700 | 500 | 6.94% |
| Dec 29, 2012 | 7,200 | 100 | 1.41% |
| Dec 31, 2011 | 7,100 | -400 | -5.33% |
| Dec 25, 2010 | 7,500 | -500 | -6.25% |
| Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
| Dec 27, 2008 | 9,000 | 500 | 5.88% |
| Dec 29, 2007 | 8,500 | 500 | 6.25% |
| Dec 30, 2006 | 8,000 | -400 | -4.76% |
| Dec 31, 2005 | 8,400 | 400 | 5.00% |
| Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
| Dec 27, 2003 | 4,500 | -500 | -10.00% |
| Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
| Dec 29, 2001 | 4,000 | 500 | 14.29% |
| Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRL News
- 2 days ago - HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 6 days ago - Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 8 days ago - Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development - Business Wire
- 10 days ago - Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities - Business Wire
- 15 days ago - Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption - Business Wire
- 16 days ago - Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call - Business Wire
- 22 days ago - Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing - Business Wire
- 23 days ago - Why Charles River Stock May Struggle In Its Final Phase - Benzinga